Europe Pancreatic Cancer Precision Medicine Market Size & Outlook
Europe pancreatic cancer precision medicine market, 2018-2030 (US$M)
Related Markets
Europe pancreatic cancer precision medicine market highlights
- The Europe pancreatic cancer precision medicine market generated a revenue of USD 173.1 million in 2024.
- The market is expected to grow at a CAGR of 18.9% from 2025 to 2030.
- In terms of segment, targeted therapy was the largest revenue generating therapeutic approach in 2024.
- Chemotherapy-Precision Combinations is the most lucrative therapeutic approach segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2025 to 2030.
Europe data book summary
| Market revenue in 2024 | USD 173.1 million |
| Market revenue in 2030 | USD 486.7 million |
| Growth rate | 18.9% (CAGR from 2025 to 2030) |
| Largest segment | Targeted therapy |
| Fastest growing segment | Chemotherapy-Precision Combinations |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Targeted Therapy, Immunotherapy, Chemotherapy-Precision Combinations, Other Therapeutic Approaches |
Other key industry trends
- In terms of revenue, Europe region accounted for 26.4% of the global pancreatic cancer precision medicine market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 450.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pancreatic Cancer Precision Medicine Market Scope
Pancreatic Cancer Precision Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe pancreatic cancer precision medicine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pancreatic cancer precision medicine market will help companies and investors design strategic landscapes.
Targeted therapy was the largest segment with a revenue share of 66.55% in 2024. Horizon Databook has segmented the Europe pancreatic cancer precision medicine market based on targeted therapy, immunotherapy, chemotherapy-precision combinations, other therapeutic approaches covering the revenue growth of each sub-segment from 2018 to 2030.
Europe pancreatic cancer precision medicine market held substantial market share in 2024, driven by rising pancreatic cancer prevalence necessitating enhanced diagnostic and therapeutic strategies. Collaborative research initiatives between academic institutions and pharmaceutical firms foster innovation in precision medicine.
Supportive regulatory environments stimulate the development and implementation of precision therapies across the continent. The pancreatic cancer precision medicine market in Germany is expected to grow in the forecast period, propelled by high pancreatic cancer incidence, accounting for approximately 3% of all cancers annually.
Germany’s advanced healthcare system facilitates integrating precision medicine into clinical practice. Significant funding for cancer research enhances the development of tailored innovative therapies for pancreatic cancer patients.
Reasons to subscribe to Europe pancreatic cancer precision medicine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe pancreatic cancer precision medicine market databook
-
Our clientele includes a mix of pancreatic cancer precision medicine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe pancreatic cancer precision medicine market , including forecasts for subscribers. This continent databook contains high-level insights into Europe pancreatic cancer precision medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe pancreatic cancer precision medicine market size, by country, 2018-2030 (US$M)
Europe Pancreatic Cancer Precision Medicine Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
